MARZOLA, Giuliano
 Distribuzione geografica
Continente #
NA - Nord America 1.746
EU - Europa 506
AS - Asia 334
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 2.589
Nazione #
US - Stati Uniti d'America 1.729
CN - Cina 178
DE - Germania 176
UA - Ucraina 102
SG - Singapore 91
FI - Finlandia 73
GB - Regno Unito 63
TR - Turchia 56
IT - Italia 51
SE - Svezia 20
CA - Canada 17
FR - Francia 5
LT - Lituania 4
BE - Belgio 3
CZ - Repubblica Ceca 3
HK - Hong Kong 3
IR - Iran 3
RU - Federazione Russa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IN - India 2
BD - Bangladesh 1
CL - Cile 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
Totale 2.589
Città #
Fairfield 226
Woodbridge 214
Houston 168
Ashburn 130
Jacksonville 117
Munich 113
Chandler 95
Ann Arbor 94
Seattle 86
Wilmington 84
Cambridge 78
Santa Clara 77
Singapore 74
Beijing 52
Helsinki 52
Nanjing 34
Izmir 29
New York 28
Shanghai 26
Boardman 25
San Diego 25
Princeton 23
Milan 21
Ferrara 16
Mcallen 13
Montréal 12
Bremen 11
Dearborn 9
Hebei 8
Nanchang 8
Shenyang 8
London 7
Los Angeles 7
Falls Church 6
Addison 5
Changsha 5
Mountain View 5
Norwalk 5
San Mateo 5
Tappahannock 5
Tianjin 5
Washington 5
Falkenstein 4
Indiana 4
Jiaxing 4
Philadelphia 4
Ardabil 3
Auburn Hills 3
Brussels 3
Clifton 3
Frankfurt am Main 3
Hong Kong 3
Olomouc 3
Ferrara di Monte Baldo 2
Jinan 2
Kunming 2
Lanzhou 2
Leawood 2
Ningbo 2
Ottawa 2
Redwood City 2
San Francisco 2
Toronto 2
Verona 2
Zhengzhou 2
Atlanta 1
Changchun 1
Chicago 1
Chongqing 1
Dhaka 1
Genoa 1
Guangzhou 1
Hangzhou 1
Hounslow 1
Kilburn 1
La Canada Flintridge 1
Las Vegas 1
Markham 1
Oklahoma City 1
Orange 1
Oslo 1
Redmond 1
Taizhou 1
Torrile 1
Warsaw 1
Wuhan 1
Xingtai 1
Yellow Springs 1
Zibo 1
Totale 2.101
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 187
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 168
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 151
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 148
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 145
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 137
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 133
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 131
Post-ischemic recovery of acetylcholine release in vitro: influence of different excitatory amino acid receptor subtype antagonists 130
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 125
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 124
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 119
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 117
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 115
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 114
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 109
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 109
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 108
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 86
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 78
null 50
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues 2. In vivo studies 26
Totale 2.610
Categoria #
all - tutte 12.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020274 0 0 0 0 0 0 47 60 48 56 46 17
2020/2021288 31 32 16 31 21 32 3 34 6 31 38 13
2021/2022281 6 31 33 17 18 13 12 20 9 26 25 71
2022/2023232 21 18 21 31 37 26 17 14 27 1 9 10
2023/2024183 14 15 11 7 9 58 8 13 4 1 8 35
2024/2025372 7 14 44 39 74 119 75 0 0 0 0 0
Totale 2.610